You are here

  • Home
  • Archive
  • Volume 55, Issue 12
  • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin

Article info

Article menu

Download PDFPDF

Original article
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
Free

Authors

  • A Torres aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • T T Bauer aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • C León-Gil aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • F Castillo aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • F Alvarez-Lerma aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • A Martínez-Pellús aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • S R Leal-Noval aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • P Nadal aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • M Palomar aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • J Blanquer aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  • F Ros aInstitut Clinic de Pneumologia i Cirurgia Toràcica, Servei de Pneumologia, UVIR, Universitat de Barcelona, IDIBAPS, Barcelona, Spain, bMedizinische Klinik, Department of Pneumology, Allergology and Sleep Medicine, Bergmannsheil Klinikum der Ruhr-Universität, Bochum, Germany, cServicio de Medicina Intensiva y Urgencias, Hospital, Universitario de Valme, Sevilla, Spain, dHospital Del Mar, Barcelona, Spain, eHospital Virgen de la Arrixaca, Murcia, Spain, fHospital Virgen del Rocío, Sevilla, Spain, gArea de Vigilancia Intensiva, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain, hServei Cures Intensives, Hospital Vall d′Hebrón, Barcelona, Spain, iRespiratory Intensive Care Unit, Hospital Clínico Universitario de Valencia, Spain, jQuimica Farmacéutica Bayer SA, Spain PubMed articlesGoogle scholar articles
  1. Dr A Torresatorres{at}medicina.ub.es
View Full Text

Citation

Torres A, Bauer TT, León-Gil C, et al
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
Thorax 2000;55:1033-1039.

Publication history

  • Received January 5, 2000
  • Revision requested March 3, 2000
  • Revised June 26, 2000
  • Accepted August 8, 2000
  • First published December 1, 2000.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Thoracic Society